SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-278621
Filing Date
2022-11-07
Accepted
2022-11-07 09:23:09
Documents
14
Period of Report
2022-11-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d387411d8k.htm   iXBRL 8-K 33495
2 EX-99.1 d387411dex991.htm EX-99.1 8230
  Complete submission text file 0001193125-22-278621.txt   205731

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA btmd-20221103.xsd EX-101.SCH 3906
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE btmd-20221103_def.xml EX-101.DEF 13675
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE btmd-20221103_lab.xml EX-101.LAB 22574
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btmd-20221103_pre.xml EX-101.PRE 14637
8 EXTRACTED XBRL INSTANCE DOCUMENT d387411d8k_htm.xml XML 5317
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

IRS No.: 851791125 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40128 | Film No.: 221364026
SIC: 2833 Medicinal Chemicals & Botanical Products